{
    "code": 0,
    "data": [
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call - Q3 - FY 2025-26",
            "news_id": "1463aa95-6fa0-4125-8196-a2c5d91d8430",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59f6ce31-d901-4d01-89b2-9ee265816dae.pdf",
            "news_date": "2026-02-11 21:24:42",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Results - Analyst/Investor Meet - Earnings Call - Q3(2025-2026) - Audio Recording",
            "news_id": "e63be24f-acac-4b72-aa67-a7fc80c2c4b3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6966d870-0ffb-4ba7-bb60-5c39b5536a83.pdf",
            "news_date": "2026-02-05 21:29:31",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the quarter and nine months ended December 31 2025",
            "news_id": "e14fe565-8695-4949-abc0-16e19c4b0abb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f761aa80-9ccc-4e05-9554-153ba6062c17.pdf",
            "news_date": "2026-02-05 14:22:14",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended December 31 2025",
            "news_body": "Unaudited standalone and Consolidated Financial Results for the Quarter and nine months ended December 31 2025",
            "news_id": "1fae70f4-d80e-4c54-8c76-b1c1a3b2d063",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3cc91ea8-f706-4bfe-bca0-c849dfef634b.pdf",
            "news_date": "2026-02-05 13:21:59",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call - Q2 & H1 FY 2025-26",
            "news_id": "b0d88c11-3666-4098-a9db-de2b9f526e27",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92ae23d9-65c0-49a7-9615-ab1442f6a19d.pdf",
            "news_date": "2025-11-12 18:49:46",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Results - Analyst/Investor Meet - Earnings Call - Q2(2025-2026) - Audio Recording",
            "news_id": "28aa6b09-09ed-4079-836c-42e5e68588eb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d5205fe-6e49-4443-b824-043d16c7b5eb.pdf",
            "news_date": "2025-11-06 18:29:06",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30Th September 2025",
            "news_body": "Un-audited standalone and consolidated financial results for the quarter and half year ended 30th September 2025",
            "news_id": "7eee53db-5a09-44e0-8d83-fabea655a89b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8f886ccc-f499-4e93-899f-4995a326fff3.pdf",
            "news_date": "2025-11-05 13:49:33",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript",
            "news_id": "aa59217c-0789-4f5e-ad15-31405fdafe95",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85d773ee-a620-46ea-8f29-0c1a72cd2a3e.pdf",
            "news_date": "2025-08-14 17:36:41",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended June 30 2025",
            "news_body": "Financial Results for the Quarter ended June 30 2025",
            "news_id": "bc51a6a6-d5ed-4ab3-bde0-ce03d99538d8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e18ffab4-fe29-41aa-a4b8-a235793e22bf.pdf",
            "news_date": "2025-08-07 13:00:25",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The link for the transcript of the earnings call w.r.t financial performance of the company for the quarter and year ended March 31 2025 is enclosed.",
            "news_id": "6d6fbdf7-35b8-4d5b-8eb9-fd4b6c1b9111",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a6d4995-6214-474e-8082-2c97831b37a6.pdf",
            "news_date": "2025-05-22 19:27:52",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "The Board Had Approved Interim Dividend For The Year Ended 31-03-2025 Along With The Audited Results. The Details Of The Same Is Enclosed Herewith.",
            "news_body": "The Board had approved interim dividend for the year ended 31-03-2025 along with the audited results. The details of the same is attached herewith.",
            "news_id": "6d883ecf-c10b-4556-862e-17e09648b25b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=190e56ba-9111-43af-aeed-7d504b231382.pdf",
            "news_date": "2025-05-15 13:42:04",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The link for the transcript of the earnings call w.r.t financial performance of the company for quarter and nine months ended 31-12-2024 is enclosed.",
            "news_id": "44001ad6-7273-4824-95d0-b417cb6789da",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=19d2fba8-78fc-4ab9-9c22-0f03546300bc.pdf",
            "news_date": "2025-02-14 18:25:25",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended December 31 2024",
            "news_body": "Financial Results along with the Limited Review Report Press Release and Investor PPT for the quarter ended December 31 2024 is enclosed",
            "news_id": "3525b30b-d13b-4b7f-8a81-021d830581ab",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a36a095-8554-4c14-bde2-44c98430b9fd.pdf",
            "news_date": "2025-02-07 13:15:53",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The weblink for the transcript is enclosed",
            "news_id": "7c5e6be5-9a44-42fb-a71e-924a1d7c769f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57c926b7-b77f-4a99-a5ef-511782e4ad2d.pdf",
            "news_date": "2024-11-14 11:28:34",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "The weblink for the audio recording of the Earnings Call for Q2/ FY 2024-25 held today, i.e. Thursday, November 07, 2024 at 16:00 hrs is enclosed",
            "news_id": "2b83870f-f02d-48b4-8565-be38b340c034",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1356b0c9-6ee1-424c-b4e6-3967588ad2a8.pdf",
            "news_date": "2024-11-07 20:22:27",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financials Results For The Quarter And Half-Year Ended September 30, 2024",
            "news_body": "Financial results for the quarter and half-year ended September 30, 2024 is enclosed",
            "news_id": "e8df6afa-1bff-4180-947a-265a0a972ec5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=773cfcec-4a44-4ac6-bd97-eed10ae85c6a.pdf",
            "news_date": "2024-11-07 13:42:17",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call - Q1 -FY 2024-25 is attached",
            "news_id": "5a0f53dd-4561-413b-a3ee-e739e433eeae",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4979a1d-2a6e-4a67-8d44-bdf01abd7ba1.pdf",
            "news_date": "2024-08-14 19:05:30",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended June 30, 2024",
            "news_body": "The financial results for the quarter ended June 30, 2024 and the other items are enclosed",
            "news_id": "24660afe-3f1c-47c0-9e35-5397866b088b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e2a9dee-61f9-43e2-b1a8-8d636de71fb7.pdf",
            "news_date": "2024-08-07 13:05:15",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Earnings Call held on May 16, 2024 is enclosed.",
            "news_id": "588b5e2a-b92c-43e7-9fe8-aa79a086686b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=39c6f2a7-ef05-474f-8415-5d6f69a0e7ee.pdf",
            "news_date": "2024-05-23 19:02:14",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Quarter And Year Ended March 31, 2024",
            "news_body": "The results for the quarter and year ended March 31, 2024 along with the details of interim divided is attached herewith",
            "news_id": "7306c1d5-1e03-4df5-a9d6-ffc4d6c6155a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6da851a4-d027-43af-a02e-8dce67d34fec.pdf",
            "news_date": "2024-05-16 13:55:17",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The link for the transcript of the earnings call w.r.t to the financial performance of the company for quarter and 9 months ended 31-12-2023 is enclosed.",
            "news_id": "57f7ee2f-8ba3-43a4-8ec4-fef9851cd980",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59a72a95-6a56-4e14-8e8d-b2853d4f0ff7.pdf",
            "news_date": "2024-02-16 17:51:48",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Website link for Audio recordings of investor meeting/ Investor call is enclosed",
            "news_id": "ff937d72-023b-42e9-a845-c3f7d2eb7516",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=93f51f85-f9be-4985-9315-f6c8948e0c59.pdf",
            "news_date": "2024-02-09 19:19:35",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended December 31, 2023",
            "news_body": "Financial Results along with the Limited Review Report, Press Release and Investor PPT for the quarter ended December 31, 2023 is enclosed",
            "news_id": "17a4ff3e-7595-4184-9cfc-4215bb4de592",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=420c65a2-0c0c-4243-87c5-1f4d961e83b9.pdf",
            "news_date": "2024-02-09 12:46:32",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript is enclosed",
            "news_id": "6ad54af8-6fbd-4987-8553-e95d50b6f1d0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f20335a2-022f-4754-bfa2-f87ef5d2c5a7.pdf",
            "news_date": "2023-11-17 22:08:36",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "In continuation to our communication dated November 03, 2023, we would like to update that the audio recording of the Earnings Call for Q2/ FY 2023-24 held today, i.e. Thursday, November 09, 2023 at 17:30 hrs (IST) has been made available on the Company's website.",
            "news_id": "51f9e0ab-ca0f-4383-8ff1-52100980832e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6c16153-5659-4c1b-b2aa-11283037ddc5.pdf",
            "news_date": "2023-11-09 22:16:06",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "In continuation to our communication dated November 03, 2023, we would like to update that the audio recording of the Earnings Call for Q2/ FY 2023-24 held today, i.e. Thursday, November 09, 2023 at 17:30 hrs (IST) has been made available on the Company's website.",
            "news_id": "5c1f8cf4-3b54-41f1-a1fe-916939abfc7f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=410388fa-981d-4c3e-a6a7-279664f582ef.pdf",
            "news_date": "2023-11-09 22:12:51",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "September 30, 2023",
            "news_body": "Financial Results for QE 30-09-2023, press release and Investor presentation is attached",
            "news_id": "ee0e4ac7-6cf5-47da-9d53-a5d4905e07dc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf4912e5-1a2a-490b-8836-04176b419bb5.pdf",
            "news_date": "2023-11-09 12:43:34",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "As Enclosed",
            "news_id": "e53d49c8-75b0-4979-b8bd-48142664bd1e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42019028-37f4-407f-a8b5-3064e379ab30.pdf",
            "news_date": "2023-08-16 21:07:37",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "As enclosed",
            "news_id": "0f53b836-d9ea-4c32-89d1-bbf3bc848f2e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8e8f313-d883-450c-9863-e3513856feaf.pdf",
            "news_date": "2023-08-16 21:02:32",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "In continuation to our communication dated August 03, 2023, we would like to update that the audio recording of the Earnings Call for Q1/ FY 2023-24 held today, i.e. Tuesday, August 08, 2023 at 11:00 hrs (IST) has been made available on the Company's website",
            "news_id": "9a4f1d97-09f8-4d99-94ca-f3a06ec67e7f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26b8d666-ebc8-4652-be1e-4c7e6553849b.pdf",
            "news_date": "2023-08-08 17:59:05",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Results and Final Dividend.",
            "news_id": "9cb736b9-e16d-48da-8504-d073086318ec",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=20775b84-8843-45b2-b130-3262c31f9b24.pdf",
            "news_date": "2023-08-07 13:53:28",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In continuation of our letter dated May 22, 2023 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the transcript of the presentation made on Saturday, May 27, 2023, on audited Financial Results (Consolidated and Standalone) of the Company for the quarter and year ended March 31, 2023, is available on the Company's website",
            "news_id": "998237f4-e0fc-47ca-a3e7-5b69e75e6ef3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bfaea454-05da-4ebf-8982-b65343bcda1e.pdf",
            "news_date": "2023-06-02 19:26:13",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Results - Analyst/Investor Meet - Earnings Call - Q4 - Audio Recording",
            "news_id": "f9ba4802-7bcc-4e03-bcef-e7465977059d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41f58b6f-82a1-4cb5-af0a-b317e76756cb.pdf",
            "news_date": "2023-05-27 18:38:58",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results For The Year Ending March 31, 2023 Along With Auditors Report",
            "news_body": "we wish to inform you that the Board of Directors, at its meeting held today, has, inter-alia, approved the following:<BR> <BR> 1. Declared an Interim Dividend of INR. 2 (100 %) per equity share of face value of INR. 2 each for the financial year ended March 31, 2023.<BR> 2. Fixed June 9, 2023 as Record Date for determining the eligibility of the Shareholders for the purpose of Interim Dividend.<BR> 3. Approved the Audited standalone and consolidated financial results (Annexure-1) of the Company as per Indian Accounting Standards for the year ending March 31, 2023 along with Auditors Report (Annexure - 2). We also enclose a Press Release issued by the Company (Annexure 3) and an investor presentation in this regard (Annexure 4).<BR> 4. Further the Nomination and Remuneration Committee of the Board of Directors of the Company, has allotted 12,000 equity shares of face value Rs. 2/- each, to the employees of the Company, upon exercise of stock options under Employee Stock Options Scheme(s) of the Company. <BR>",
            "news_id": "9198809e-fca7-43fa-ba3c-c11c15e74c1b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d4e5988-ff97-4272-83ba-19a911bf07e2.pdf",
            "news_date": "2023-05-27 12:43:30",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "we wish to inform you that the Board of Directors, at its meeting held today, has, inter-alia, approved the following:<BR> <BR> 1. Declared an Interim Dividend of INR. 2 (100 %) per equity share of face value of INR. 2 each for the financial year ended March 31, 2023.<BR> 2. Fixed June 9, 2023 as Record Date for determining the eligibility of the Shareholders for the purpose of Interim Dividend.<BR> 3. Approved the Audited standalone and consolidated financial results (Annexure-1) of the Company as per Indian Accounting Standards for the year ending March 31, 2023 along with Auditors Report (Annexure - 2). We also enclose a Press Release issued by the Company (Annexure 3) and an investor presentation in this regard (Annexure 4).<BR> 4.Further the Nomination and Remuneration Committee of the Board of Directors of the Company, has allotted 12,000 equity shares of face value Rs. 2/- each, to the employees of the Company, upon exercise of stock options under Employee Stock Options Scheme(s) of the Company. <BR>",
            "news_id": "4094f8b9-4f27-454b-9b85-2e14e03fcb9d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1eaa7e59-64ec-4af2-b7e5-8ac1a3170192.pdf",
            "news_date": "2023-05-27 12:38:26",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended December 31, 2022",
            "news_body": "Further to our intimation dated January 28, 2023 we wish to inform you that the Board of Directors of the Company at its meeting held today has, inter-alia approved the Un-audited standalone and consolidated financial results and the Limited Review Report (Annexure-1) of the Company as per Indian Accounting Standards for the quarter and nine months ended December 31, 2022. We also enclose a Press Release issued by the Company (Annexure 2) and an investor presentation in this regard (Annexure 3).",
            "news_id": "537a74a8-b06a-40b3-af5f-9d51bcbac1e9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92e4f686-6b42-461f-8009-4d1c5dc7c1a3.pdf",
            "news_date": "2023-02-11 13:32:42",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On February 11, 2023",
            "news_body": "Further to our intimation dated January 28, 2023 we wish to inform you that the Board of Directors of the Company at its meeting held today has, inter-alia approved the Un-audited standalone and consolidated financial results and the Limited Review Report (Annexure-1) of the Company as per Indian Accounting Standards for the quarter and nine months ended December 31, 2022. We also enclose a Press Release issued by the Company (Annexure 2) and an investor presentation in this regard (Annexure 3).",
            "news_id": "0f3e410b-5649-4ec5-97eb-436768cad44e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5b2dbd8-d76a-48b3-9a76-8b5c1a2601d3.pdf",
            "news_date": "2023-02-11 13:28:50",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosure of Related Party Transactions for the half year ended September 30, 2022. You are requested to take the above on record .",
            "news_id": "e3237222-3a46-4a8d-983a-ecfd197abd2a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a7351f2c-1666-43b4-b3e7-9821ca2896b7.pdf",
            "news_date": "2022-11-27 22:35:04",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Standalone And Consolidated Financial Results  For Quarter And Half-Year Ended September 30, 2022",
            "news_body": "Un-audited standalone and consolidated financial results  for quarter and half-year ended September 30, 2022",
            "news_id": "ee533a08-dbba-4b3c-b536-1c9d8640cfe6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af857f9a-aabb-449a-9cfc-49f0f0997396.pdf",
            "news_date": "2022-11-12 13:46:11",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "news_id": "365543d3-c7b3-4936-bc58-af267c437e5d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc41489c-ced1-4512-af60-8a094f41c370.pdf",
            "news_date": "2022-08-05 13:06:40",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Disclosure of Related Party Transactions pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015",
            "news_id": "ff39c753-db98-4fc9-bbdc-58388b8add1a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43b2e504-9b0f-4b72-9e85-dfb74d2eb857.pdf",
            "news_date": "2022-06-02 15:22:31",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Results - Analyst/Investor Meet - Earnings Call - Q4 - Audio Recording",
            "news_id": "5b4883fa-64b7-41dd-87c3-b9d7d7f698ab",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f4b1e2c-749b-4ac4-8073-a1efebb7d9c0.pdf",
            "news_date": "2022-05-12 17:53:38",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting -",
            "news_body": "1. Declared an Interim Dividend of Rs. 2/- (100 %) per equity share of Rs.2 each for the financial year ended March 31, 2022.<BR> 2. Fixed 24th May 2022 as Record Date for determining the eligibility of the Shareholders for the purpose of Interim Dividend.<BR> 3. Approved the Audited standalone and consolidated financial results (Annexure-1) of the Company as per Indian Accounting Standards for the year ending March 31, 2022 along with Auditors Report (Annexure - 2). We also enclose a Press Release issued by the Company (Annexure 3) and an investor presentation in this regard (Annexure 4).",
            "news_id": "596c3335-0257-4c5d-94db-5d83706e5fcf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf50f672-3eb2-4338-92fb-b378c23d3e4c.pdf",
            "news_date": "2022-05-12 13:03:06",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results - Financial Results For The Quarter And Nine Months Ended December 31, 2021.",
            "news_body": "Further to our intimation dated January 28, 2022, we wish to inform you that the Board of Directors of the Company at its meeting held today has, inter-alia approved the Un-audited standalone and consolidated financial results and the Limited Review Report (Annexure-1) of the Company as per Indian Accounting Standards for the quarter and nine months ended December 31, 2021. We also enclose a Press Release issued by the Company (Annexure 2) and an investor presentation in this regard (Annexure 3).<BR> <BR> The meeting commenced at 11:00 A.M and concluded at 12:45 P.M.<BR> <BR> Kindly take the same on your records.<BR> <BR>",
            "news_id": "04114dd0-0f9f-4820-935b-0297b62053cd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44581acd-0ea9-49a3-b9df-d8f95d05cf93.pdf",
            "news_date": "2022-02-03 13:02:43",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For The Quarter And Six Months Ended September 30, 2021.",
            "news_body": "Unaudited Standalone and Consolidated Financial Results for the quarter and six months ended September 30, 2021.",
            "news_id": "9f11abac-1ca3-4685-a821-f24f0ca38a5f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3797fad6-7930-4f6d-91c9-371df60d37ab.pdf",
            "news_date": "2021-11-02 12:56:34",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Compliance under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015",
            "news_id": "1da67cf1-d73c-46a5-a001-7acdfd080cd3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=30f8d312-3f19-490f-b564-5eec109e3ae3.pdf",
            "news_date": "2021-10-30 15:59:22",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approved The Un-Audited Standalone And Consolidated Financial Results And The Limited Review Report Of The Company As Per Indian Accounting Standards For The Quarter Ending 30Th June, 2021.",
            "news_body": "Approved the Un-audited standalone and consolidated financial results and the Limited Review Report of the Company as per Indian Accounting Standards for the quarter ending 30th June, 2021.",
            "news_id": "b5a6b0ed-65ac-4cfc-b9d1-8b2a5e56cb80",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=472350cf-bfce-46ce-81a0-d39f6b8d5fd3.pdf",
            "news_date": "2021-08-05 12:38:51",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "news_id": "54e8a475-507c-4b6e-80f9-2e2021d2bdfc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da9b67e2-3d8c-4b26-bc91-f174ef9bd459.pdf",
            "news_date": "2021-08-05 12:27:42",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Disclosure of Related Party Transactions pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015",
            "news_id": "2ba1a408-29dc-4a73-b3ea-21e86cfbb6f6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73452d73-1922-43f4-846a-18cde9dfc314.pdf",
            "news_date": "2021-06-04 14:25:40",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "news_id": "71a8d6ee-2ec4-404a-b19e-d4079707d3b8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7cefe864-dbb0-4bdf-b400-b51d421e5ed0.pdf",
            "news_date": "2021-05-06 13:06:34",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "CAPLIPOINT",
            "disp": "Caplin Point Laboratories",
            "bse_code": 524742,
            "isin": "INE475E01026",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "news_id": "770237d9-a8b8-4242-8551-d19c6fe8e7b1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a3fee06-9961-42b3-8f05-a9adfe7233f1.pdf",
            "news_date": "2021-05-06 13:02:39",
            "seo": "caplin-point-laboratories-ltd",
            "ltp": 1746.7,
            "ch": 15,
            "pch": 0.8662008431021538,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3906,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}